Status:
WITHDRAWN
Writing to Alleviate Violence Exposure for Transgender Women (WAVE-TW)
Lead Sponsor:
University of Miami
Collaborating Sponsors:
Empower U Community Health Center
Miami Center for AIDS Research at the University of Miami Miller School of Medicine
Conditions:
PTSD
Depression
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
WAVE - TW (Writing to Alleviate Violence Exposure for Transgender women living with HIV) is an intervention development study which aims to assess the feasibility and acceptability of a proposed traum...
Eligibility Criteria
Inclusion
- Living with HIV
- Age 18 or older
- Detectable viral load within the past year
- Transgender female
- English speaking
- Capable of completing and fully understanding the informed consent process and the study procedures
- History of trauma/abuse
Exclusion
- Unable to completely and fully understand the consent process and the study procedures.
- Significant interfering mental health symptoms (e.g., untreated active psychosis, active suicidality with a plan).
- Engaged in an intervention to address trauma symptoms and adherence within the past year
Key Trial Info
Start Date :
October 22 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 15 2021
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04305977
Start Date
October 22 2020
End Date
October 15 2021
Last Update
February 17 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UHealth Don Soffer Clinical Research Building
Miami, Florida, United States, 33136